BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20127359)

  • 1. Expression of metalloproteases and their inhibitors by tumor and stromal cells in ductal carcinoma in situ of the breast and their relationship with microinvasive events.
    González LO; González-Reyes S; Junquera S; Marín L; González L; Del Casar JM; González JM; Vizoso F
    J Cancer Res Clin Oncol; 2010 Sep; 136(9):1313-21. PubMed ID: 20127359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of matrix metalloproteinases and their tissue inhibitors in ductal in situ carcinomas of the breast.
    Gonzalez LO; Corte MD; Vazquez J; Junquera S; Sanchez R; Viña A; Rodriguez JC; Lamelas ML; Vizoso F
    Histopathology; 2008 Oct; 53(4):403-15. PubMed ID: 18983606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of metalloproteases and their inhibitors in different histological types of breast cancer.
    Del Casar JM; González-Reyes S; González LO; González JM; Junquera S; Bongera M; García MF; Andicoechea A; Serra C; Vizoso FJ
    J Cancer Res Clin Oncol; 2010 Jun; 136(6):811-9. PubMed ID: 19916023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal cells associated with early invasive foci in human mammary ductal carcinoma in situ coexpress urokinase and urokinase receptor.
    Nielsen BS; Rank F; Illemann M; Lund LR; Danø K
    Int J Cancer; 2007 May; 120(10):2086-95. PubMed ID: 17290405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of matrix metalloproteinases and their inhibitors in pure and mixed invasive and in situ ductal carcinomas of the breast.
    Gonzalez LO; Junquera S; del Casar JM; González L; Marín L; González-Reyes S; Andicoechea A; González-Fernández R; González JM; Pérez-Fernández R; Vizoso FJ
    Hum Pathol; 2010 Jul; 41(7):980-9. PubMed ID: 20236691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumor stromal fibroblasts and those at the invasive front of breast carcinomas.
    Del Casar JM; González LO; Alvarez E; Junquera S; Marín L; González L; Bongera M; Vázquez J; Vizoso FJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):39-52. PubMed ID: 19241156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical study of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinase 1 in benign and malignant breast tissue--strong expression in intraductal carcinomas of the breast.
    Rahko E; Kauppila S; Pääkkö P; Blanco G; Apaja-Sarkkinen M; Talvensaari-Mattila A; Turpeenniemi-Hujanen T; Jukkola A
    Tumour Biol; 2009; 30(5-6):257-64. PubMed ID: 19887890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas.
    Nielsen BS; Rank F; López JM; Balbin M; Vizoso F; Lund LR; Danø K; López-Otín C
    Cancer Res; 2001 Oct; 61(19):7091-100. PubMed ID: 11585740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis.
    Fernandez-Garcia B; Eiró N; Marín L; González-Reyes S; González LO; Lamelas ML; Vizoso FJ
    Histopathology; 2014 Mar; 64(4):512-22. PubMed ID: 24117661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of stromal metalloproteases expression in patients with benign hyperplasia and prostate cancer.
    Escaff S; Fernández JM; González LO; Suárez A; González-Reyes S; González JM; Vizoso FJ
    J Cancer Res Clin Oncol; 2011 Mar; 137(3):551-5. PubMed ID: 20508949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors.
    Gonzalez LO; Corte MD; Vazquez J; Junquera S; Sanchez R; Alvarez AC; Rodriguez JC; Lamelas ML; Vizoso FJ
    BMC Cancer; 2008 May; 8():149. PubMed ID: 18507821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometase/matrilysin-2 in human breast ductal carcinoma in situ and its inhibition by tissue inhibitors of metalloproteinases-2 and -4: a putative role in the initiation of breast cancer invasion.
    Zhao YG; Xiao AZ; Park HI; Newcomer RG; Yan M; Man YG; Heffelfinger SC; Sang QX
    Cancer Res; 2004 Jan; 64(2):590-8. PubMed ID: 14744773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low microvascular density at the tumor center is related to the expression of metalloproteases and their inhibitors and with the occurrence of distant metastasis in breast carcinomas.
    Fernández-Guinea O; Álvarez-Cofiño A; Eiró N; González LO; del Casar JM; Fernandez-Garcia B; Lamelas ML; Andicoechea A; Vizoso FJ
    Int J Clin Oncol; 2013 Aug; 18(4):629-40. PubMed ID: 22688161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix-metalloproteinases 1, 2, and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization study.
    Brummer O; Athar S; Riethdorf L; Löning T; Herbst H
    Virchows Arch; 1999 Dec; 435(6):566-73. PubMed ID: 10628798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collagen (XI) alpha-1 chain is an independent prognostic factor in breast ductal carcinoma in situ.
    Toss MS; Miligy IM; Gorringe KL; Aleskandarany MA; Alkawaz A; Mittal K; Aneja R; Ellis IO; Green AR; Rakha EA
    Mod Pathol; 2019 Oct; 32(10):1460-1472. PubMed ID: 31175327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.
    Sharma M; Beck AH; Webster JA; Espinosa I; Montgomery K; Varma S; van de Rijn M; Jensen KC; West RB
    Breast Cancer Res Treat; 2010 Sep; 123(2):397-404. PubMed ID: 19949854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ.
    Sopik V; Sun P; Narod SA
    Breast Cancer Res Treat; 2018 Feb; 167(3):787-795. PubMed ID: 29119353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encapsulated papillary carcinoma of the breast: a study of invasion associated markers.
    Rakha EA; Tun M; Junainah E; Ellis IO; Green A
    J Clin Pathol; 2012 Aug; 65(8):710-4. PubMed ID: 22554960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between metalloprotease expression in tumour and stromal cells and aggressive behaviour in prostate carcinoma: Simultaneous high-throughput study of multiple metalloproteases and their inhibitors using tissue array analysis of radical prostatectomy samples.
    Fernandez-Gomez J; Escaf S; Gonzalez LO; Suarez A; Gonzalez-Reyes S; González J; Miranda O; Vizoso F
    Scand J Urol Nephrol; 2011 Apr; 45(3):171-6. PubMed ID: 21244194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of the expression of metalloproteases and their inhibitors in different localizations within primary tumours and in metastatic lymph nodes of breast cancer.
    García MF; González-Reyes S; González LO; Junquera S; Berdize N; Del Casar JM; Medina M; Vizoso FJ
    Int J Exp Pathol; 2010 Aug; 91(4):324-34. PubMed ID: 20412339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.